|Bid||0.3102 x 1100|
|Ask||0.3200 x 900|
|Day's Range||0.2801 - 0.3610|
|52 Week Range||0.1700 - 0.7700|
|Beta (5Y Monthly)||2.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.10|
Subscribe to Yahoo Finance Plus to view Fair Value for NBY
EMERYVILLE, Calif., August 04, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
EMERYVILLE, Calif., July 28, 2022--NovaBay Pharmaceuticals targets the lash extension market with antimicrobial Avenova lid and lash spray.
EMERYVILLE, Calif., July 21, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the availability of select DERMAdoctor products at two popular U.S. online retailers, Target.com and Urbanoutfitters.com.